Clinical Trials Browser

Phase 2 × Completed × Glutamine × Clear all

NCT01607879 2023-09-22

Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

Phase 2 Completed

48 enrolled 15 charts

EndocrineGenitourinary

Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2 Completed

56 enrolled 5 charts

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT00255229 2016-02-25

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

Phase 2 Completed

130 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00003898 2011-03-01

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Phase 2 Completed

120 enrolled

Other solid neoplasm

Oral Complications